Forgot Password

Hearing loss cord blood trials

Autologous stem cell infusion for children with acquired hearing loss

The trial is being undertaken at the Florida Hospital in Orlando, Florida. The purpose of this study is to determine if autologous (child’s own) umbilical cord blood infusion in children with acquired hearing loss is safe, feasible, improves inner ear function, audition and language development. Researchers aim to enrol 10 children between 6 weeks to 6 years of age.  All participants will receive a single infusion of their own cord blood. The estimated completion date for this study is January 2016.

Location: Florida, USA
Trial design: Safety study
Status: Open – recruiting 
Find out more